Integra Lifesciences Holdings Corp (IART) SEC Filings — 2024
19 SEC filings for Integra Lifesciences Holdings Corp (IART) in 2024.
Filings
- Integra LifeSciences Appoints New CFO, Elects Directors — 8-K · Dec 17, 2024
- Integra Lifesciences Holdings Corp SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Integra Lifesciences Holdings Corp SC 13G Filing — SC 13G · Nov 12, 2024
- Integra LifeSciences Files Q3 2024 10-Q — 10-Q · Nov 4, 2024
- Integra Lifesciences Holdings Corp SC 13G/A Filing — SC 13G/A · Aug 12, 2024
- Integra LifeSciences Files 10-Q for Q2 2024 — 10-Q · Jul 29, 2024
- Integra Lifesciences Holdings Corp SC 13G/A Filing — SC 13G/A · Jul 8, 2024
- Integra LifeSciences Sells Cadence Science for $30M — 8-K · May 17, 2024
- Integra LifeSciences to Acquire Acclarent for $271M — 8-K · May 13, 2024
- Integra Lifesciences Holdings Corp. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 6, 2024
- Integra LifeSciences Holdings Corp. Files Definitive Proxy Statement — DEF 14A · Apr 4, 2024
- Integra LifeSciences Holdings Corp. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Integra LifeSciences Amends Officer & Director Changes Filing — 8-K/A · Feb 27, 2024
- Champlain Investment Partners Maintains Passive Stake in Integra LifeSciences — SC 13G/A · Feb 13, 2024
- Vanguard Amends Integra LifeSciences Stake as of Dec 29, 2023 — SC 13G/A · Feb 13, 2024
- Capital Research Global Investors Reports 4.29M Share Stake in IART — SC 13G · Feb 9, 2024
- Wellington Management Trims Integra LifeSciences Stake to 6.13% — SC 13G/A · Feb 9, 2024
- Morgan Stanley Amends Integra Lifesciences (IART) Stake — SC 13G/A · Feb 9, 2024
- BlackRock Amends Integra LifeSciences Stake to 8.6% — SC 13G/A · Jan 25, 2024